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Myosin has an intrinsic ability to organize into ordered thick ﬁlaments that mediate muscle contrac-
tion. Here, we use surface plasmon resonance and light scattering analysis to further characterize
the molecular determinants that guide myosin ﬁlament assembly. Both assays identify a cluster
of lysine and arginine residues as important for myosin polymerization in vitro. Moreover, in cardio-
myocytes, replacement of these charged residues by alanine severely affects the incorporation of
myosin into the distal ends of the sarcomere. Our ﬁndings show that a novel assembly element with
a distinct charge proﬁle is present at the C-terminus of sarcomeric myosins.
Structured summary of protein interactions:
WT LMM binds to WT LMM by surface plasmon resonance (View Interaction)
WT LMM binds to CT2 LMM by surface plasmon resonance (View Interaction)
WT LMM binds to Alanine mutant LMM by surface plasmon resonance (View Interaction)
WT LMM and WT LMM bind by light scattering (View Interaction)
Alanine mutant LMM and Alanine mutant LMM bind by light scattering (View Interaction)
WT LMM and Alanine mutant LMM bind by light scattering (View Interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The ability of myosin II to move along actin ﬁlaments is central
to the function of striated muscles. The motion driven by the enzy-
matic activity of the myosin head is dependent on the ability of the
coiled coil structure of the myosin rod to assemble into thick ﬁla-
ments [1]. This process is driven by charge interactions occurring
along the rod [2], and by sequence determinants located in the
C-terminal portion of the molecule also known as light meromyo-
sin (LMM) [3]. Myosin and LMM are soluble in high salt but insol-
uble in physiological salt solutions. Under these conditions, LMM
forms periodic paracrystalline assemblies. These arrays are gener-
ally accepted as surrogates for myosin thick ﬁlaments because they
show characteristic repeats at 43 and 14.3 nm [4]. Using a combi-
nation of differential solubility and paracrystal assays, a conserved
29-residue region named Assembly Competence Domain (ACD)
was identiﬁed as a critical modulator of LMM assembly in vitro
[3]. Moreover, detailed sequence analysis revealed that the ACD
is part of a longer conserved C-terminal region characterized by
an unusual distribution of apolar amino acids and a unique charge
proﬁle [5]. We have sought to broaden these earlier observationschemical Societies. Published by E
. Leinwand).by monitoring LMM assembly with surface plasmon resonance
(SPR), light scattering (LS) and cellular assays. This integrated ap-
proach has allowed identiﬁcation of a cluster of four positive resi-
dues, not previously identiﬁed in paracrystal assays, that is
important for myosin polymerization in vitro and incorporation
into sarcomeres in cultured cardiac cells. The data presented add
new valuable information to the molecular processes that promote
myosin assembly.
2. Materials and methods
2.1. Expression vectors and proteins
The WT-LMM sequence corresponding to residues 1231–1938
of rat a-cardiac myosin, was initially ampliﬁed from pMT21a plas-
mid with Pfu DNA polymerase using forward and reverse primers
carrying the XhoI and SpeI restriction sites respectively. The result-
ing blunt end PCR product that introduces 2 extra amino acids at
the beginning and at the end of LMM (L-E and T-S, respectively),
was then cloned into pUC18 SmaI site for mutagenesis. To avoid
aggregation through oxidation, the 3 cysteine residues present
along the protein (C1341, C1412, and C1749) were replaced by ser-
ines. These modiﬁcations, as well as the truncations and point
mutations introduced in the LMM analyte constructs were carriedlsevier B.V. All rights reserved.
Fig. 1. Binding of WT-LMM analyte to WT-LMM ligand depends on protein
concentration, pH and salt concentration. The ligand was equilibrated in 10 mM
TES at the pH and NaCl concentrations indicated below. Binding was initiated by
ﬂowing a solution of analyte over the ligand at protein concentration, pH, and NaCl
molarity shown on the right side of each sensorgram in Panel A, B and C,
respectively. At the time indicated by the asterisk, the analyte solution was replaced
by 10 mM TES/300 mMNaCl. The SPR sensorgram shown in Panel A was obtained at
pH 7.3, NaCl 150 mM and analyte concentrations as indicated. The analyte
concentration in the sensorgrams shown in Panels B and C was 0.45 mM: the
reactions were carried out in NaCl 150 mM at the pH values indicated (panel B) and
at pH 7.3 at the NaCl concentration indicated (panel C).
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were conﬁrmed by sequencing. Constructs were double digested
with XhoI and SpeI, and the resulting LMM fragments were then
inserted into a modiﬁed pET3a expression vector. This cloning
added N-terminal T7 and 6X-His tags, and a C-terminal Cys residue
to the LMM proteins. Finally, for the SPR assay, the amino acid se-
quence MAGC was added to the N- terminus of the ligand to allow
a unique point of attachment to the chip. EGFP and mCherry myo-
sin tagged constructs were generated by fusing each ﬂuorescent
reporter gene at amino acid 841 of the rat a-cardiac myosin gene
as previously described [6].
Recombinant proteins used in SPR and LS assays were expressed
in Escherichia coli BL21 (DE3) as previously described [7]. Protein
purity was assessed by polyacrylamide gel electrophoresis, and rel-
ative concentrations were determined by BCA assay (Pierce) using
BSA as a standard. Proteins were stored as small aliquots at pH 7.3
in 0.5 M NaCl at 80 C.
2.2. NRVM preparation and transfection
Neonatal rat ventricular myocytes (NRVMs) were prepared
from Sprague–Dawley neonatal rat hearts as previously described
[8]. Cells were electroporated using the Rat Cardiomyocyte-Neona-
tal Nucleofector Kit (Lonza) according to the manufacturer’s proto-
col and plated onto 1% gelatin coated glass coverslips. Following
overnight recovery, cells were washed and then treated with
15 mM L-Phenylephrine. After 48 h, cells on the coverslips were
ﬁxed with 4% paraformaldehyde, mounted with Vectashield
(Vector Laboratories) and analyzed by confocal microscopy with
a Nikon Eclipse TE 2000-U microscope. Imaging was performed
with the 100X Nikon Plan Apo VC oil objective. MetaMorph
software was used for image acquisition and cell image analysis.
2.3. Surface plasmon resonance (SPR)
All experiments were made in a Biacore model X (GE). LMM li-
gand was attached to a sensor C1 chip (GE) by ﬁrst derivatizing
both Biacore ﬂow cells with ethylenediamine according to the
manufacturer’s directions, and then reacting the free amino group
with a solution of 250 mg N-gamma-maleimidobutyryloxy succin-
imidyl ester (Pierce) in 20 ml 0.1 M sodium bicarbonate pH 8.8 to
produce ﬂow cells with N-alkyl maleimide groups. Unreacted ami-
no groups were blocked by reaction with sulfo-NHS acetate (Ther-
moScientiﬁc) in 0.1 M sodium bicarbonate (pH 8.8). 50 ml of
0.1 mM LMM ligand in 0.5 M NaCl, 0.5 mM Tris (2-carboxy-
ethyl)phosphine at pH 7.3 was run over ﬂow cell 2 (Fc2) at
20 ml per minute; the amount of protein attached varied from
200 to 300 RU, where 1 RU (Resonance Units) corresponds to
about 1.2 pg of protein. A solution of 50 mM b-mercaptoethanol
was used to block unreacted maleimides in Fc 1 and Fc 2 cells.
For binding assays, the chip was ﬁrst washed with 6 M guanidi-
nium chloride and then equilibrated for 2 min with 10 mM TES
pH 7.3, 150 mM NaCl, and 3.5 mM EDTA. Immediately after dilu-
tion from 300 to 150 mM NaCl, 70 ml of analyte solution was ﬂo-
wed over the two cells at 20 ml per minute; the sensorgram
ordinate (RU) represents the difference between binding of ana-
lyte to Fc 2 and Fc 1.
2.4. Light scattering (LS)
Light scattering at 320 nm was measured as previously de-
scribed, in a PTI QM-2000-6SE ﬂuorescence spectrometer (Photon
Technology International) at 25 C with a 2 and 8 nm slit width
for excitation and emission respectively [7]. To show that the
changes observed were reversible, 5 M NaCl was added at the
end of each assembly reaction (carried out at 150 mM NaCl) to
bring the ﬁnal salt concentration to 300 mM.3. Results and discussion
3.1. Surface plasmon resonance (SPR) assay for LMM assembly
To better deﬁne the sequence determinants and the earliest
events of LMM assembly, we have developed a novel approach
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ular interactions [9]. In our assay, we measure the non-covalent
binding of LMM analyte in solution to the LMM ligand immobilized
on the biosensor chip. As the ligand and analyte interact, the for-
mation of a myosin polymer on the chip increases the refractive in-
dex of the solution proportionally to the mass of analyte bound.
Thus, a real-time quantiﬁcation of the early steps of assembly of
the WT and mutant LMM can be carried out.
Fig. 1A shows the results of a typical experiment in which WT-
LMM ligand (residues 1231–1938), covalently attached to the chip
through a Cys at its N-terminus, was exposed to solutions of WT-
LMM analyte in 150 mM NaCl at pH 7.3. At analyte concentrations
greater than 0.2 lM the amount of LMM bound increases with time
with a rate that is approximately ﬁrst order in protein concentra-
tion. Since the amount of non-covalently bound LMM analyte
quickly exceeds stoichiometric equivalence with the covalently
bound LMM ligand (see Section 2.3) the LMM analyte is either poly-
merizing on the LMM ligand, or is polymerizing in solution and then
binding to the LMM ligand. The complex formed under these condi-
tions dissociates rapidly when high-salt buffer replaces the analyte
(asterisks in each panels). The kinetics of dissociation are complex
anddonot lend themselves to a simple analysis of this process. Poly-
merization of LMM on the ligand is very sensitive to the pH and salt
concentration of the solution of analyte. At pH 8.0, the amount of
LMM analyte bound to the LMM ligand is less than 5% of that bound
at pH 7.3 (Fig. 1B). A similar reduction in binding is seen when the
salt concentration is raised to 200mM from150 mM (Fig. 1C). These
effects of pH and ionic strength on assembly are consistent with anFig. 2. LMM analyte truncations and amino acid substitutions affect the binding to WT-LM
correspond to truncations of 6 and 20 amino acids respectively at the carboxyl-termin
KLRAKSR sequence are shown in red. Binding reactions in Panels A, and B were carr
respectively. The bottom of the ﬁgure shows the sequence of the last 67 amino acids of t
positive charges identiﬁed in this study (bold), their relative heptad repeat position, andassembly process that is driven by ionic interactions between LMM
molecules as observed for myosin [10,11].
3.2. A novel assembly determinant in the C-terminus of LMM
Earlier work has suggested that interactions involving the C-ter-
minus of LMM are important for assembly into paracrystals [3,12].
To further deﬁne those amino acid residues responsible for assem-
bly we have investigated the properties of a number of C-terminally
truncated LMM analytes in the SPR assay (Fig. 2A). While binding
was hardly affected by truncation of the C-terminal 6 amino acids
(CT1), it was severely reduced by truncation of the C-terminal 20
residues of LMM (CT2). Little further loss of ability to assemble
was detected when the analyte was further shortened by 28 amino
acids (data not shown).
To further localize the residues in the C-terminal region identi-
ﬁed by the truncation analysis as being important for the polymer-
ization reaction, we closely examined the sequence contained in
the CT2 deletion and focused on a cluster of four charged amino
acids, (KLRAKSR, residues 1920–1926) which we postulated could
be involved in ionic interactions between adjacent coiled-coils
since present in the exposed positions of the heptad repeat
(Fig. 2, bottom). In accord with our hypothesis, simultaneous
replacement of all four positively charged residues with alanine re-
duced the LMM analyte’s ability to bind to the LMM ligand
(Fig. 2B). Interestingly, the alanine replacement mutagenesis has
a greater impact on polymerization than the CT2 truncation. We
believe that this difference could be ascribable to the differentM ligand. Truncation analysis (A): LMM corresponds to the WT-LMM; CT1 and CT2
us of LMM. Amino acid substitution analysis (B): the alanine replacements in the
ied out in 150 mM NaCl, pH 7.3 and analyte concentrations of 0.5, and 0.6 mM,
he rat a-myosin, containing the assembly competence domain (ACD), the cluster of
the CT1 and CT2 deletions shown in Panel A.
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leave the end of the rod negatively charged (4 negative residues are
in fact present downstream of the KLRAKSR sequence) the trunca-
tion neutralizes this effect. Although alanine substitution of the
ﬁrst two positive charges (K1920 and R1922) or the last two
(K1924 and R1926) also resulted in a reduction of the protein’s
ability to polymerize on the LMM ligand, single residue replace-
ments tested in each position of the positive cluster did not affect
the reaction (data not shown).
3.3. Light scattering (LS) assay for LMM assembly
A decrease in SPR signal could result from impaired binding of
the mutant analyte to the WT ligand, or impaired self-polymeriza-
tion of the mutant. To discriminate between these two alterna-
tives, we examined LMM assembly using the LS assay. Previously
established for studying the formation of myosin-II miniﬁlaments
in Acanthamoeba [13], the LS assay has been recently used in our
lab to study the effects of pathogenic myosin mutations on myosin
assembly [7]. Since molecules scatter light according to their
molecular weight, the extent of LMM polymerization can be deter-
mined by this assay. As for SPR, the LS assay shows that LMM poly-
merization is dependent on its concentration (Fig. 3A) and on the
ionic strength of the solution (data not shown). At LMM concentra-
tions between 0.25 and 0.5 mM, there appears to be a lag in the for-
mation of light scattering complex, indicating that under these
conditions, formation of a small intermediate(s) may be rate-deter-
mining for the overall assembly process. At the concentrations
used in this study, the ﬁnal level of light scattering does not de-
crease on extended incubation, indicating that the complex formed
does not precipitate from solution. The absence of any measurableFig. 3. The C-terminal ALAAASA mutant cannot self-polymerize or efﬁciently co-
polymerize with the WT-LMM. (A) WT-LMM self-polymerization depends on
protein concentration. At the time indicated by the asterisk, the NaCl concentration
was increased from 150 to 300 mM to show the reversibility of the assembly
reaction. The concentration of WT-LMM tested are shown on the right side of each
curve; the intensity of the light scattering is plotted in arbitrary units (AU) versus
time. (B) WT-LMM and ALAAASAmutant self-polymerization reactions were carried
out at 0.7 mM; for co-polymerization analysis the ﬁnal total protein concentration
was 1.4 mM. The linear response of the assay at higher protein concentration was
veriﬁed by monitoring the WT-LMM self-polymerization reaction at 2 lM.increase in light scattering observed when the C-terminal KLR-
AKSR?ALAAASA mutant was assayed indicates that the loss of
the four positive residues severely affects the ability of LMM to
self-polymerize (Fig. 3B, red curve). This result also suggests that
the dramatic signal reduction observed in the SPR assay with the
same mutant is probably due to lack of analyte self-polymeriza-
tion. Moreover, mixing equimolar amounts of the ALAAASAmutant
with wild-type LMM only slightly enhanced the extent of light
scattering (Fig. 3B, purple curve) indicating that the mutant cannot
efﬁciently copolymerize with, or inhibit the polymerization of the
wild-type protein.
3.4. The KLRAKSR sequence is important for assembly in myocytes
To extend our in vitro results into the biological context of a
muscle cell background, we next investigated whether the alanine
mutations in the KLRAKSR affect assembly of myosin into the sar-
comere. Neonatal rat cardiac myocytes (NRVMs) were co-transfec-
ted with a plasmid expressing the mutant rat a-myosin rod N-
terminally fused to GFP and a plasmid expressing the WT rat a-
myosin fused to mCherry, and subsequently imaged by confocal
microscopy. As shown in Fig. 4, the myosin mutant was incorpo-
rated into the sarcomere but its presence was mainly restricted
to the bare zone, where the myosin molecules organize in an anti-
parallel arrangement, and was only barely detectable along the A
band (HMV and Linescan). However, the presence of the mutant
does not affect efﬁcient incorporation of the WT mCherry myosin
along the sarcomere. The intensity of the ﬂuorescence signal spik-
ing at the center of the bare zone suggests that the mutant is incor-
porated into the sarcomere but may assemble incorrectly; loss of
interactions between the mutant and the myomasp/LRRC39 pro-
tein that interacts with the C-terminal region of myosin, could in
fact result in a change of rod localization in the M-band [14]. Inter-
estingly, a similar phenotype has been previously described for a
rod mutation causing Laing distal myopathy [6]. The reduction in
the fraction of mutant localized in the sarcomere arms indicates
that the positively charged side chains could primarily be involved
in the interactions occurring between parallel coiled-coils. These
data also concur with the result obtained with the LS assay: lack
of dominant negative effects on WT mCherry myosin incorporation
and limited assembly in the sarcomere bare zone match the mixing
experiment presented in Fig. 3 (purple curve).
3.5. The cationic cyclical pattern of the KLRAKSR sequence is unique
Using a combined biochemical and cellular approach we have
found that four positive charges located in the KLRAKSR sequence
(AA 1920–1926 of the a-cardiac myosin) are important for thick ﬁl-
ament formation. These positive residues are highly conserved
among all muscle myosin isoforms as well as across different spe-
cies (for a detailed analysis see the myosin-weighted consensus se-
quence available at http://bmf2.colorado.edu/myomapr/ [15]).
Their identiﬁcation is of special signiﬁcance since the last two K
and R amino acids were previously identiﬁed as important for sar-
comere assembly in Caenorhabditis elegans [16]. The importance of
these residues for myosin assembly in cardiac myocytes, and nem-
atodes indicates that there are signiﬁcant similarities between the
biochemically and biologically accessible vertebrate systems and
the genetically accessible nematode system. This suggests that
hypotheses generated in either of these systems can be usefully
investigated in the other in a way that will beneﬁt our understand-
ing of both.
The KLRAKSR region lies in the extended ACD region that lacks
the periodicity of positive and negative charges that characterize
the rest of the myosin rod, and shows a distinctive distribution
of charges and a high proportion of large apolar residues in surface
Fig. 4. The ALAAASA mutant is incorporated into sarcomeres but accumulates in the bare zone. Neonatal rat ventricular myocytes were co-transfected with GFP- and
mCherry-WT myosin rods (Top Panel), or with GFP-mutant myosin (ALAAASA) and mCherry-WT myosin rods (Bottom Panel). Representative images from the mCherry and
GFP channels are shown together with the merge. HMV: high magniﬁcation view of merged images. Linescan: analysis of the relative intensity of wt-mCherry myosin and
GFP-myosin mutant along four sarcomeres. Asterisks indicate accumulation of the ALAAASA mutant in the bare zone. The bar represents 10 lm.
3012 R.C. Thompson et al. / FEBS Letters 586 (2012) 3008–3012positions [5]. Remarkably, the topology of the lysine and arginine
residues is unique: four alternating positively charged residues
(clustering in c, e, g and b positions of the heptad repeat). We have
considered the possibility that the alanine substitutions could hin-
der the formation of the rod coiled-coil structure by disrupting sta-
bilizing ion pairs between the two a-helices. However, the ﬁrst R
(R1922) and the second K (K1924) are predicted to form ionic pairs
with residues 1917 and 1929 of the partner helix [17,18]. The ﬁnd-
ing that in rat a-myosin these positions are occupied by Q and G
residues respectively, strongly suggests that inter-helical electro-
static interactions do not occur in this region. Thus, we believe that
the four positive residues contained in the KLRAKSR sequence are
involved in higher-level assembly of the coiled-coils. In particular,
based on the in vivo experiments that show a preferential exclu-
sion of the mutant from the arms of the sarcomere, we propose
that the positive character of the KLRAKSR sequence mainly pro-
motes parallel assembly of adjacent coiled-coils. Interestingly,
one-dimensional modeling of electrostatic interactions between
the 4 positive residues K-R-K-R and anionic partners located at
the predicted rod staggers of 43/14.3 nm [2], identiﬁes the se-
quences EGDLNEME (AA 1620–1628; negative charges located in
e, g, c, and e positions of the heptad repeat) and RELENELE (AA
1821–1828; negative charges located in c, e, g, and b positions of
the heptad repeat) as potential candidates for ionic pairing.
By deﬁning new sequences involved in thick ﬁlament forma-
tion, our data may be useful to better understand the links be-
tween mutations occurring in the myosin assembly domain and
a growing class of myopathies [19].Acknowledgements
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